Everett E. Vokes to Farnesyltranstransferase
This is a "connection" page, showing publications Everett E. Vokes has written about Farnesyltranstransferase.
Connection Strength
0.117
-
Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting. Lung Cancer. 2003 Aug; 41 Suppl 1:S115-21.
Score: 0.059
-
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2003 May 01; 21(9):1760-6.
Score: 0.058